Immunotherapy Demonstrates Long-term Success In Treating Lymphoma

Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus...

Read the whole article on Science Daily

More from Science Daily